Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001437749-12-001692
Filing Date
2012-02-23
Accepted
2012-02-23 16:06:10
Documents
18
Period of Report
2011-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K pdl_10k-123111.htm 10-K 2202446
2 EXHIBIT 10.46 ex10-46.htm EX-10.46 41686
3 EXHIBIT 10.47 ex10-47.htm EX-10.47 23053
4 EXHIBIT 10.48 ex10-48.htm EX-10.48 13621
5 EXHIBIT 12.1 ex12-1.htm EX-12.1 45131
6 EXHIBIT 21.1 ex21-1.htm EX-21.1 6081
7 EXHIBIT 23.1 ex23-1.htm EX-23.1 14408
8 EXHIBIT 31.1 ex31-1.htm EX-31.1 11737
9 EXHIBIT 32.1 ex32-1.htm EX-32.1 7818
16 logo2.jpg GRAPHIC 8748
17 chart2.jpg GRAPHIC 35183
18 logo.jpg GRAPHIC 7917
  Complete submission text file 0001437749-12-001692.txt   13234037

Data Files

Seq Description Document Type Size
10 XBRL INSTANCE pdli-20111231.xml EX-101.INS 2561714
11 XBRL TAXONOMY EXTENSION SCHEMA pdli-20111231.xsd EX-101.SCH 83318
12 XBRL TAXONOMY EXTENSION CALCULATION pdli-20111231_cal.xml EX-101.CAL 31978
13 XBRL TAXONOMY EXTENSION DEFINITION pdli-20111231_def.xml EX-101.DEF 395594
14 XBRL TAXONOMY EXTENSION LABELS pdli-20111231_lab.xml EX-101.LAB 499008
15 XBRL TAXONOMY EXTENSION PRESENTATION pdli-20111231_pre.xml EX-101.PRE 452869
Mailing Address 932 SOUTHWOOD BLVD INCLINE VILLAGE NV 89451
Business Address 932 SOUTHWOOD BLVD INCLINE VILLAGE NV 89451 775-832-8500
PDL BIOPHARMA, INC. (Filer) CIK: 0000882104 (see all company filings)

EIN.: 943023969 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-19756 | Film No.: 12633916
SIC: 2836 Biological Products, (No Diagnostic Substances)